NCT01414816View on ClinicalTrials.gov

Betaferon® Regulatory Post-Marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

355

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Multiple SclerosisClinically Isolated System
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

EOD, dosage frequency and duration will be decide by physicians.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01414816 - Betaferon® Regulatory Post-Marketing Surveillance | Biotech Hunter | Biotech Hunter